Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: I can’t reliably say which telehealth services “still” offer compounded GLP‑1s right now — availability changed rapidly after the FDA/FTC actions in 2023–2024 and my browsing/data cut off in June 2024. The safer approach is to avoid compounded GLP‑1s and get an FDA‑approved product prescribed and dispensed by a licensed prescriber and pharmacy.

What the FDA warned about

• The FDA has raised safety/quality concerns about compounded versions of GLP‑1 peptides (sterility, dose accuracy, lack of clinical testing) and has taken enforcement action against some compounding pharmacies and sellers.
• Using compounded GLP‑1s can carry higher risks than FDA‑approved drugs.

Safer alternatives — FDA‑approved GLP‑1 brand drugs

• Semaglutide: Ozempic (mostly for diabetes), Wegovy (for weight loss)
• Tirzepatide: Mounjaro (diabetes), Zepbound (weight‑loss)
• Liraglutide: Saxenda (weight loss)
  These are the products you should try to obtain through legitimate prescription channels rather than seeking compounded versions.

Telehealth services that (as of mid‑2024) commonly prescribe FDA‑approved GLP‑1s If your goal is to get a legitimate, FDA‑approved GLP‑1 via telehealth, these national telehealth/virtual care companies were commonly used:

• Hims & Hers (Hims) — publicly stated GLP‑1 programs and telemedicine visits for weight loss; direct pharmacy fulfillment.
• Ro (Roman/Ro Clinic) — offers weight‑loss programs and pharmacy fulfillment for prescribed GLP‑1s.
• PlushCare — board‑certified physicians who manage chronic conditions and weight‑loss meds.
• One Medical — primary‑care centric; continuity of care and in‑network prescribing of GLP‑1s.
• GoodRx Care — telehealth visits plus couponing/pharmacy options that can be used for GLP‑1 prescriptions.
• Amwell / Doctor on Demand / Teladoc — large telemedicine platforms whose clinicians may prescribe GLP‑1s when clinically appropriate.

Why these are safer choices

• These companies generally connect you to licensed clinicians and use standard pharmacies (not unnamed compounding shops). They are more likely to prescribe FDA‑approved formulations and provide follow‑up care and monitoring.

If you’re still considering compounded GLP‑1s

• Be cautious. If a telehealth provider or pharmacy offers a compounded GLP‑1, ask:
  • Is this an FDA‑approved product or a compounded formulation?
  • Which pharmacy is doing the compounding? Is it state‑licensed and USP‑compliant (ask about USP <797>/<795> or accreditation)?
  • Can you provide sterility testing and lot traceability?
  • Why is a compounded product being used instead of an FDA‑approved option?
• Consider discussing risks with your primary care clinician or an endocrinologist before using compounded peptides.

If you want, tell me a specific telehealth company you’re interested in and I’ll draft the exact questions to ask them (or summarize publicly known policies up to mid‑2024).